Phase 2 HIV Clinical Trials
57 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–20 of 57 trials
Recruiting
Phase 2
Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer
HIV InfectionAnal Squamous Cell CarcinomaStage II Rectal Cancer AJCC v8+7 more
National Cancer Institute (NCI)40 enrolled14 locationsNCT04929028
Recruiting
Phase 2
Imaging and Biopsy of People With HIV-1 Undergoing Analytic Treatment Interruption
HIV
National Cancer Institute (NCI)50 enrolled1 locationNCT05419024
Recruiting
Phase 2
A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
HIV Infections
ViiV Healthcare150 enrolled62 locationsNCT07202546
Recruiting
Phase 2
Evaluating the Safety and Immunogenicity of MTBVAC
TuberculosisHIV I Infection
HIV Vaccine Trials Network276 enrolled16 locationsNCT05947890
Recruiting
Phase 2
COVID-19 Booster and IIV Schedule in Immunocompromised Hosts
COVID-19Inflammatory Bowel DiseaseRheumatoid Arthritis (RA)+5 more
McGill University Health Centre/Research Institute of the McGill University Health Centre660 enrolled3 locationsNCT06599658
Recruiting
Phase 1Phase 2
Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ...
Hematologic MalignanciesHIV
National Cancer Institute (NCI)265 enrolled1 locationNCT05470491
Recruiting
Phase 1Phase 2
Exploratory Study of LP-98 for Injection in ART-Naive HIV-Infected Individuals
HIV
Shanxi Kangbao Biological Product Co., Ltd.30 enrolled1 locationNCT07433387
Recruiting
Phase 2
Improving Physical Ability and Cellular Senescence Elimination in HIV
FrailtyHIVAging Problems+1 more
National Institute of Allergy and Infectious Diseases (NIAID)80 enrolled27 locationsNCT07144293
Recruiting
Phase 2
Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Aged 4 Weeks to <12 Years and <45 kg (MK-1439-066)
Human Immunodeficiency Virus (HIV) Infection
Merck Sharp & Dohme LLC84 enrolled24 locationsNCT04375800
Recruiting
Phase 2Phase 3
A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
Human Immunodeficiency Virus Type 1 (HIV-1) Infection
Merck Sharp & Dohme LLC570 enrolled24 locationsNCT07266831
Recruiting
Phase 1Phase 2
Effects of Vagal Dysfunction on Gastrointestinal and Inflammatory Pathways in HIV
HIVNon-HIVVagus Nerve Dysfunction
Icahn School of Medicine at Mount Sinai207 enrolled1 locationNCT04353778
Recruiting
Phase 2
HIV-1 Virologic Suppression With TMB-365 and TMB-380 Antibodies Study
HIV-1-infection
TaiMed Biologics Inc.75 enrolled11 locationsNCT07215468
Recruiting
Phase 2
An Integrated Intervention Using a Pill Ingestible Sensor System
Medication AdherenceSocial Determinants of Health (SDOH)HIV/AIDS
University of California, Los Angeles110 enrolled1 locationNCT06480578
Recruiting
Phase 1Phase 2
Evaluation of Safety, Immunogenicity and Efficacy of a Triple Immune Regimen in Adults Initiated on ART During Acute HIV-1
HIV-1-infection
National Institute of Allergy and Infectious Diseases (NIAID)36 enrolled12 locationsNCT06071767
Recruiting
Phase 2
Combination Vaccination and Broadly Neutralising Antibody Therapy in HIV
HIV
University of Oxford48 enrolled3 locationsNCT07054931
Recruiting
Phase 2
Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 1
Alcohol Use DisorderHIV
Yale University30 enrolled1 locationNCT06004830
Recruiting
Phase 2
Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 3 Semaglutide
HIVAlcohol Use Disorder (AUD)
Yale University30 enrolled1 locationNCT07040592
Recruiting
Phase 2
A Phase Ⅱa Clinical Study of CL-197 Capsules
HIV-1-infection
Henan Genuine Biotech Co., Ltd.24 enrolled1 locationNCT07308782
Recruiting
Phase 2Phase 3
Platform Trial For Cryptococcal Meningitis
HIVCryptococcal Meningitis
University of Minnesota2,000 enrolled2 locationsNCT06666322
Recruiting
Phase 2
Effect of Empagliflozin on Metabolic Outcomes in Adults Living With HIV Receiving Dolutegravir-Based Therapy
Metabolic SyndromeObesity, OverweightHIV (Human Immunodeficiency Virus)
Abdelrahman Mahmoud66 enrolled1 locationNCT07336797